Matteo Garibaldi

Pubblicazioni

Titolo Pubblicato in Anno
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE 2024
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease BRAIN 2024
MiR206 and 423‑3p Are Differently Modulated in Fast and Slow‑Progressing Amyotrophic Lateral Sclerosis Patients NEUROMOLECULAR MEDICINE 2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) NEUROLOGICAL SCIENCES 2024
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 2024
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study JOURNAL OF NEUROLOGY 2024
Clinical, histopathologic, and genetic features of patients with myofibrillary and distal myopathies NEUROLOGY 2024
Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study ANTIOXIDANTS 2024
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors Focus on Chronic Toxicities NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION 2024
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report FRONTIERS IN ONCOLOGY 2024
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients CLINICAL EPIGENETICS 2024
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients BIOMOLECULES 2023
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies. An Italian Nationwide Survey NEUROLOGY 2023
NEFL-RELATED CHARCOT-MARIE TOOTH DISEASE DUE TO P440L MUTATION IN TWO ITALIAN FAMILIES: EXPANDING THE PHENOTYPE AND DEFINING MODULATING FACTORS EUROPEAN NEUROLOGY 2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients NEUROLOGICAL SCIENCES 2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases CURRENT NEUROPHARMACOLOGY 2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 2023
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? NEUROLOGICAL SCIENCES 2023
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors NEUROLOGICAL SCIENCES 2023
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? ANNALS OF NEUROLOGY 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma